Cognitive improvement after treatment of depressive symptoms in the acute phase of stroke

Completed

Phase N/A Results

Summary of Purpose

To investigate the efficacy of citalopram in treating depressive symptoms in acute stroke patients, as well as determining the outcome, cognitive impairment, and cognitive domains most improved following treatment.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 August 2006.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Schering-Plough

Trial Design

Double-blinded, controlled trial.

Contacts

Not available